Randall Marshall

US·SEC (Form 4)

Protara Therapeutics, Inc.

Cumul. flow

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (40 ops.)

€1.5M

Latest filing published 15 Sept 2020 for Protara Therapeutics, Inc., €34k.

Filing timeline

BuySale

Randall Marshall

Insider track record

Disclosed buys

Disclosed sells

Signal history

Randall Marshall: trading record in brief

Randall Marshall discloses dealings in Protara Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 9 January 2020 to 14 September 2020, the count stands at 41 filings.

Sales make up the whole of the open-market record (40 sales, €1.5M). The rest of the record consists of 1 share grant.

The latest filing, published on 15 September 2020, reports an open-market sale of €34k in Protara Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Randall Marshall

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Protara Therapeutics, Inc. (US)

Declarations41 total

▼
Randall Marshall
Executives14 Sept 2020Protara Therapeutics, Inc.
40,061 USD2SEC
2,080 shares@ US$19.262.2% of flowCommon StockSEC:0001179110-20-009785:0
▼
Randall Marshall
Executives14 Sept 2020Protara Therapeutics, Inc.
9,480 USD2SEC
474 shares@ US$20.000.5% of flowCommon StockSEC:0001179110-20-009785:1
▼
Randall Marshall
10% OwnerExecutives10 Sept 2020Protara Therapeutics, Inc.
4,302 USD5SEC
239 shares@ US$18.000.2% of flowCommon StockSEC:0001179110-20-009717:0
▼
Randall Marshall
10% OwnerExecutives8 Sept 2020Protara Therapeutics, Inc.
58,866 USD5SEC
3,108 shares@ US$18.943.3% of flowCommon StockSEC:0001179110-20-009662:0
▼
Randall Marshall
10% OwnerExecutives9 Sept 2020Protara Therapeutics, Inc.
96,093 USD6SEC
5,309 shares@ US$18.105.4% of flowCommon StockSEC:0001179110-20-009662:1
▼
Randall Marshall
10% OwnerExecutives9 Sept 2020Protara Therapeutics, Inc.
94,674 USD6SEC
4,913 shares@ US$19.275.3% of flowCommon StockSEC:0001179110-20-009662:2
▼
Randall Marshall
10% OwnerExecutives2 Sept 2020Protara Therapeutics, Inc.
4,281 USD5SEC
207 shares@ US$20.680.2% of flowCommon StockSEC:0001179110-20-009590:0
▼
Randall Marshall
10% OwnerExecutives3 Sept 2020Protara Therapeutics, Inc.
1,050 USD5SEC
52 shares@ US$20.190.1% of flowCommon StockSEC:0001179110-20-009590:1
▼
Randall Marshall
10% OwnerExecutives28 Aug 2020Protara Therapeutics, Inc.
17,031 USD5SEC
771 shares@ US$22.091.0% of flowCommon StockSEC:0001179110-20-009466:0
▼
Randall Marshall
10% OwnerExecutives26 Aug 2020Protara Therapeutics, Inc.
31,763 USD5SEC
1,418 shares@ US$22.401.8% of flowCommon StockSEC:0001179110-20-009407:0
▼
Randall Marshall
10% OwnerExecutives27 Aug 2020Protara Therapeutics, Inc.
13,780 USD5SEC
616 shares@ US$22.370.8% of flowCommon StockSEC:0001179110-20-009407:1
▼
Randall Marshall
10% OwnerExecutives24 Aug 2020Protara Therapeutics, Inc.
22,558 USD5SEC
974 shares@ US$23.161.3% of flowCommon StockSEC:0001179110-20-009359:0
▼
Randall Marshall
10% OwnerExecutives25 Aug 2020Protara Therapeutics, Inc.
55,939 USD5SEC
2,461 shares@ US$22.733.1% of flowCommon StockSEC:0001179110-20-009359:1
▼
Randall Marshall
10% OwnerExecutives20 Aug 2020Protara Therapeutics, Inc.
12,332 USD5SEC
510 shares@ US$24.180.7% of flowCommon StockSEC:0001179110-20-009241:0
▼
Randall Marshall
10% OwnerExecutives18 Aug 2020Protara Therapeutics, Inc.
5,038 USD5SEC
200 shares@ US$25.190.3% of flowCommon StockSEC:0001179110-20-009191:0
▼
Randall Marshall
10% OwnerExecutives14 Aug 2020Protara Therapeutics, Inc.
17,563 USD5SEC
700 shares@ US$25.091.0% of flowCommon StockSEC:0001179110-20-009153:0
▼
Randall Marshall
10% OwnerExecutives17 Aug 2020Protara Therapeutics, Inc.
38,870 USD5SEC
1,548 shares@ US$25.112.2% of flowCommon StockSEC:0001179110-20-009153:1
▼
Randall Marshall
10% OwnerExecutives29 Jul 2020Protara Therapeutics, Inc.
16,368 USD5SEC
600 shares@ US$27.280.9% of flowCommon StockSEC:0001179110-20-008623:1
▼
Randall Marshall
10% OwnerExecutives29 Jul 2020Protara Therapeutics, Inc.
2,845 USD5SEC
100 shares@ US$28.450.2% of flowCommon StockSEC:0001179110-20-008623:2
▼
Randall Marshall
10% OwnerExecutives30 Jul 2020Protara Therapeutics, Inc.
34,426 USD5SEC
1,317 shares@ US$26.141.9% of flowCommon StockSEC:0001179110-20-008623:3
▼
Randall Marshall
10% OwnerExecutives29 Jul 2020Protara Therapeutics, Inc.
47,270 USD5SEC
1,816 shares@ US$26.032.7% of flowCommon StockSEC:0001179110-20-008623:0
▼
Randall Marshall
10% OwnerExecutives27 Jul 2020Protara Therapeutics, Inc.
8,815 USD5SEC
338 shares@ US$26.080.5% of flowCommon StockSEC:0001179110-20-008539:0
▼
Randall Marshall
10% OwnerExecutives28 Jul 2020Protara Therapeutics, Inc.
69,810 USD5SEC
2,600 shares@ US$26.853.9% of flowCommon StockSEC:0001179110-20-008539:1
▼
Randall Marshall
10% OwnerExecutives28 Jul 2020Protara Therapeutics, Inc.
51,849 USD5SEC
1,811 shares@ US$28.632.9% of flowCommon StockSEC:0001179110-20-008539:2
▼
Randall Marshall
10% OwnerExecutives28 Jul 2020Protara Therapeutics, Inc.
433,272 USD7SEC
14,243 shares@ US$30.4224.5% of flowCommon StockSEC:0001179110-20-008539:3

25 of 41 declarations

Randall Marshall

Insider track record

Randall Marshall: trading record in brief

Companies and markets linked to Randall Marshall

Similar companies

Related executives